123.No

Bli kontaktet av fagfolk som har kompetanse og erfaring med installasjon av varmepumpe.

Best forex bonuses

Trykk pгґ lenken under og fyll inn litt informasjon om hva det er du гёnsker, deretter sender vi deg flere gode tilbud fra kompetente og erfarne installatгёrer. Du velger selv hvilket tilbud du vil gгґ for.

FГҐ gode tilbud pгґ varmepumpe

Spar bгґde penger og miljгёet - fгґ flere tilbud pгґ varmepumper fra kompetente installatгёrer i dag.

Luft-til-luft
varmepumpe

Luft-til-vann
varmepumpe

VГ¦ske-til-vann
varmepumpe

Andre varmepumper/
veiledning

Slik fungerer det

Beskriv oppdraget

Legg enkelt inn en beskrivelse av hva du trenger hjelp til.

Motta flere tilbud

Bli kontaktet av fagfolk som har kompetanse og erfaring med installasjon av varmepumpe.

Sammenlign og velg

Inviter pгґ befaring, sammenlign tilbudene og velg det beste lгёsningen for deg.

Tre fordeler med varmepumpe

Kom i gang allerede i dag!В

Bedre komfort i hjemmet

Med oppvarming pгґ kalde vinterdager og kjгёling pгґ varme sommerdager, sikrer en varmepumpe en behagelig temperatur i hjemmet ditt гґret rundt.

Reduserer strгёmforbruket

Med riktig bruk og montering sparer du mye penger. Г…rsaken er enkel; en varmepumpe leverer mer varme eller kjгёling enn hva den faktisk bruker av strгёm. Avhengig av type varmepumpe kan du spare mellom 30 % og 75 % strгёm til oppvarming og varmtvann.

Miljгёvennlig oppvarming

En varmepumpe henter gratis energi fra omgivelsene ved ГҐ bruke fornybar norsk strгёm. En varmepumpe sparer bгґde lommeboka og miljгёet ved at den reduserer energiforbruket til boligen betraktelig.

Innholdet pгґ denne siden er kvalitetssikret av varmepumpeforeningen вђ“ varmepumpeinfo.No

FГҐ tilbud pгґ varmepumpe

Spar bгґde penger og miljгёet - fгґ flere tilbud pгґ varmepumper fra kompetente installatгёrer i dag.

Vantagens do mundo 123

Reembolsos

Devolvemos-lhe uma percentagem dos pagamentos que já faz no dia a dia:

Com o seu cartão de crédito mundo 123, no supermercado, em restaurantes e muito mais.

Excluindo todas as transações relacionadas com pagamentos ao estado, pagamentos efetuados por entidade e referência, jogos de fortuna e azar, compras em estações de serviço e operações de compra e venda de moeda estrangeira e aquelas cuja natureza seja a de transferência de fundos (incluindo através de vales postais ou carregamento de cartões recarregáveis emitidos por outras instituições financeiras) ou que consistam na subscrição de produtos financeiros ou instrumentos de dívida pública.

1 milha por cada euro nas compras

Pode optar por converter o valor das compras em milhas do programa SATA imagine, na proporção de 1 milha por cada euro.

2% nas contas da casa: luz, água, gás, TV, internet, telefone e telemóvel

Pagas por débito direto na conta à ordem mundo 123, até ao limite de 350€/mês.

Pago através da conta à ordem mundo 123 por netbanco, app santander, ao balcão ou por ATM (multibanco). Excluem-se os pagamentos em TPA (terminal de pagamento automático).

3% na utilização da via verde

Em portagens, estacionamento, abastecimentos, ferry e restaurantes com drive in, pagos com o identificador associado ao cartão de crédito mundo 123.

Até 12 cênt/litro ao abastecer na repsol

6 cêntimos por litro de desconto imediato + 6 cêntimos por litro de reembolso no cartão de crédito mundo 123 nas estações repsol aderentes em portugal continental e na madeira
- ou -

4 cêntimos por litro (3 cêntimos por litro de desconto imediato + 1 cêntimo por litro de reembolso no cartão de crédito mundo 123) nas estações repsol e azoria aderentes nos açores.

Limitado a 3 transações e a 200€ por dia, nas estações de serviço aderentes, excepto em pagamentos de self-service.

Para beneficiar da atribuição do desconto imediato e reembolso nos abastecimentos de combustível deverá sempre e obrigatoriamente:

Efectuar o pagamento com o seu cartão mundo 123 para atribuição posterior do reembolso.

Se apresentar outro cartão de fidelização para obter um desconto imediato superior e/ou outros benefícios o pagamento com o cartão mundo 123 não produz efeito para o reembolso, nem terá direito ao desconto imediato subjacente ao cartão mundo 123.

15% de desconto em compras em makenotes.Pt

Aproveite o voucher de 15% de desconto em múltiplas compras em makenotes.Pt até 30 de novembro de 2021.

Para ter acesso a este desconto, só tem de entrar no netbanco, consultar o separador “mundo 123” e escolher “O que tenho no mundo 123”.

Esta oferta é da exclusiva responsabilidade do parceiro makenotes.

Todos os reembolsos são efetuados na conta-cartão mundo 123. As transações efetuadas com o cartão mundo 123 em compras, utilização da via verde, combustível abastecido e pagamento do IMI são consideradas, em conjunto, até ao limite máximo de utilização de 1 200€ (conta mundo 123 e conta ordenado mundo 123) ou 1 600€ (conta select mundo 123 e conta ordenado select mundo 123 – contas fora de comercialização) por período de extrato mensal. Adicionalmente, o montante dos benefícios associados às contas mundo 123 e select mundo 123 (conta fora de comercialização) tem um limite máximo de reembolso de 6€, à conta ordenado mundo 123 tem um limite máximo de reembolso de 12€ e à conta ordenado select mundo 123 (conta fora de comercialização) tem um limite máximo de reembolso de 16€, por período de extrato mensal.

Klondike solitaire | play online for free

How to play klondike solitaire

Solitaire is a game of patience that, as the name suggests, is played alone!

The game's layout consists of three different parts:

The "tableau" consists of 28 cards made up of 7 piles that increase in size. Each pile has the corresponding number of cards: the 1st pile has 1 card, the 2nd has 2, the third has 3, etc. Up to the pile with 7 cards. At the start of the game, only the top card is face up.

The "reserve" (otherwise known as depot) consists of the remaining 24 cards of the game that are stacked face down.

The "foundations" consist of 4 freecells, usable from the beginning of the game.

The goal of klondike solitaire is to fill the 4 foundations by following ascending suit sequences (ace, two, three, four, five, six, seven, eight, nine, ten, jack, queen, and king) of the same suit (clubs, spades, diamonds, or hearts).

In the tableau's piles, follow descending suit sequences (king, queen, jack, 10, 9, 8, 7, 6, 5, 4, 3, 2, ace) with alternating colors (red or black: the card suit does not matter).

You can only place kings on the tableau's freecells.

You can move descending sequences of any number of cards to another pile , or move an entire pile to a new cell.

When useful, you can take a card from one of the 4 Foundations, and place it on the Tableau.

Draw a card from the reserve if there are no more possibles moves.

Your current browser is outdated!

Sorry, it appears you are using an internet browser that is not currently supported.

Please update your browser or install one of the following:

Petite école de la mélodie, op.123 (dancla, charles)

Содержание

Performances

Sheet music

Scores and parts

Suite 1

PDF scanned by schalltrichter
schalltrichter ( 2013/3/13 )

Polka (no.6)

PDF scanned by squarepeg
squarepeg ( 2009/1/20 )

Suite 2

Arrangements and transcriptions

Selections

For 3 violins (dessauer)

Suite 1

For orchestra (diz)

PDF typeset by arranger
ezequiel diz (2018/9/13)

⇒ 13 more: flute 1, 2 • oboe 1, 2 • clarinet 1, 2 (B♭) • bassoon 1, 2 • alto saxophone (E♭) • tenor saxophone (B♭) • timpani • percussion • violins I • violins II • violas • cellos • basses

PDF typeset by arranger
ezequiel diz (2018/9/13)

General information

Pub history:
first? Published in 1868, as 12 pieces (publication noted in the journal de l'imprimerie et de la librairie en belgique, (vol.15, 1868, p.47, r.516).); then published by schott, perhaps with some augmentation (13 pieces, 2 suites. ) in 1869/70 ( hofmeister's monatsbericht (1870), p.19 .)
1871 suite 1 and 2 for 2 vl hofmeister's monatsbericht (1871), p.266
1881 suite 3 for vl piano hofmeister's monatsbericht (1881), p.138
1886 arr for viola or cello p (original piano score) hofmeister's monatsbericht (1886), p.4

Klondike solitaire | play online for free

How to play klondike solitaire

Solitaire is a game of patience that, as the name suggests, is played alone!

The game's layout consists of three different parts:

The "tableau" consists of 28 cards made up of 7 piles that increase in size. Each pile has the corresponding number of cards: the 1st pile has 1 card, the 2nd has 2, the third has 3, etc. Up to the pile with 7 cards. At the start of the game, only the top card is face up.

The "reserve" (otherwise known as depot) consists of the remaining 24 cards of the game that are stacked face down.

The "foundations" consist of 4 freecells, usable from the beginning of the game.

In the tableau's piles, follow descending suit sequences (king, queen, jack, 10, 9, 8, 7, 6, 5, 4, 3, 2, ace) with alternating colors (red or black: the card suit does not matter).

You can only place kings on the tableau's freecells.

You can move descending sequences of any number of cards to another pile , or move an entire pile to a new cell.

When useful, you can take a card from one of the 4 Foundations, and place it on the Tableau.

Draw a card from the reserve if there are no more possibles moves.

Your current browser is outdated!

Sorry, it appears you are using an internet browser that is not currently supported.

Please update your browser or install one of the following:

123.No

We introduce a new picture of vacuum decay which, in contrast to existing semiclassical techniques, provides a real-time description and does not rely on classically forbidden tunneling paths. Using lattice simulations, we observe vacuum decay via bubble formation by generating realizations of vacuum fluctuations and evolving with the classical equations of motion. The decay rate obtained from an ensemble of simulations is in excellent agreement with existing techniques. Future applications include bubble correlation functions, fast decay rates, and decay of nonvacuum states.

Published by the american physical society under the terms of the creative commons attribution 4.0 international license. Further distribution of this work must maintain attribution to the author(s) and the published article’s title, journal citation, and DOI. Funded by SCOAP 3 .

Published by the american physical society

Physics subject headings (physh)

Authors & affiliations

Jonathan braden 1,* , matthew C. Johnson 2 , hiranya V. Peiris 1,3 , andrew pontzen 1 , and silke weinfurtner 4

1 department of physics and astronomy, university college london, gower street, london, WC1E 6BT, united kingdom

2 department of physics and astronomy, york university, toronto, ontario, M3J 1P3, canada and perimeter institute for theoretical physics, 31 caroline street N, waterloo, ontario, N2L 2Y5, canada

3 the oskar klein centre for cosmoparticle physics, stockholm university, albanova, stockholm, SE-106 91, sweden

4 school of mathematical sciences, university of nottingham, university park, nottingham, NG7 2RD, united kingdom and centre for the mathematics and theoretical physics of quantum non-equilibrium systems, university of nottingham, nottingham, NG7 2RD, united kingdom

* corresponding author. Jbraden@cita.Utoronto.Ca

Article text

Supplemental material

References

Issue

COVID-19 has impacted many institutions and organizations around the world, disrupting the progress of research. Through this difficult time APS and the physical review editorial office are fully equipped and actively working to support researchers by continuing to carry out all editorial and peer-review functions and publish research in the journals as well as minimizing disruption to journal access.

We appreciate your continued effort and commitment to helping advance science, and allowing us to publish the best physics journals in the world. And we hope you, and your loved ones, are staying safe and healthy.

Many researchers now find themselves working away from their institutions and, thus, may have trouble accessing the physical review journals. To address this, we have been improving access via several different mechanisms. See off-campus access to physical review for further instructions.

Tools

Follow journal

Cancer

Export citations

Issue information

Issue information – TOC

Cancerscope

Study to examine genetic factors behind increased risk of breast cancer in african americans

Studies show high anxiety and depression among individuals with cancer

Breast cancer mortality rates decline internationally, with some major exceptions

Editorials

Age, hepatitis C virus infection, and the risk of cancer: unlocking a complex puzzle of interactions

Hepatitis C infection may increase the risk of various malignancies among older adults. A better understanding of the complex biology of the aging process and hepatitis C infection may help to unlock an important piece of the puzzle in the world of cancer development.

Primary tumor resection does not improve survival among patients with unresectable colorectal cancer metastases—but who determines resectability?

Conclusive data do not support routine asymptomatic, primary tumor resection among patients with unresectable colorectal cancer metastases. However, the authors strongly caution against an extrapolation of this conclusion that deters patients with stage IV disease from being referred for consideration of potentially curative metastasectomy.

Sexual and relationship health among survivors of oropharyngeal or oral cavity squamous cell carcinoma

Six months after diagnosis, some patients with oral squamous cell carcinoma have decreased their sexual behavior, whereas others have stopped having sex, highlighting a patient group that could benefit from more relationship‐oriented support. However, most patients remain sexually active and report strong relationship dynamics, and they indicate that having a human papillomavirus‐related diagnosis does not appear to add additional marital stress or change sexual intimacy beyond that experienced by patients with human papillomavirus‐unrelated oral squamous cell cancer.

Review articles

Recommendations for the standardization of bone marrow disease assessment and reporting in children with neuroblastoma on behalf of the international neuroblastoma response criteria bone marrow working group

Susan A. Burchill phd, bsc

Klaus beiske MD, phd

Hiroyuki shimada MD, phd

Peter F. Ambros phd, bsc

Robert seeger MD, msc

Godelieve A.M. Tytgat MD, phd

Penelope R. Brock MD, phd

Michelle haber dsc, phd, bsc

Julie R. Park MD

Frank berthold MD

Pages: 1095-1105

First published: 16 december 2016

Practical transferable recommendations with which to standardize the quantitative reporting of bone marrow disease in children with neuroblastoma are provided by the multidisciplinary international neuroblastoma response criteria bone marrow working group. The wide adoption of these harmonized criteria will enhance the ability to compare outcomes from different trials and facilitate collaborative trial design.

Diagnosis and treatment of epidural metastases

Epidural metastases occur in 5% to 10% of cancer patients and represent a neurological emergency. The timely initiation of radiation as well as surgery in select cases is critical for preserving neurological function and for achieving local tumor control and pain control.

Original articles

Disease site

Breast disease

Prognostic significance of equivocal human epidermal growth factor receptor 2 results and clinical utility of alternative chromosome 17 genes in patients with invasive breast cancer: A cohort study

Nour sneige MD

Kenneth R. Hess phd

Asha S. Multani phd

Yun gong MD

Nuhad K. Ibrahim MD

Pages: 1115-1123

First published: 28 november 2016

Equivocal human epidermal growth factor receptor 2 (HER2) results resemble HER2‐negative cases, not HER2‐amplified cases. Alternative chromosome 17 probes are not effective in determining the HER2 status, so their use is not recommended in daily clinical practice.

Gastrointestinal disease

Comparative effectiveness of primary tumor resection in patients with stage IV colon cancer

Zeinab alawadi MD, MS

Uma R. Phatak MD, MS

Chung‐yuan hu MPH, phd

Christina E. Bailey MD, MSCI

Y. Nancy you MD, MSHS

Lillian S. Kao MD, MS

Nader N. Massarweh MD, MPH

Barry W. Feig MD

Miguel A. Rodriguez‐bigas MD

John M. Skibber MD

George J. Chang MD MS

Pages: 1124-1133

First published: 01 august 2016

The role of primary tumor resection among patients who have colorectal cancer with unresectable metastases remains a topic of debate. After accounting for treatment selection and survivor time biases, primary tumor resection does not improve survival; therefore, it should not be routinely performed in asymptomatic patients.

Gastrointestinal disease

Clinical and genetic determinants of ovarian metastases from colorectal cancer

Karuna ganesh mbbchir, phd

Ronak H. Shah BS

Efsevia vakiani MD, phd

Garrett M. Nash MD, MPH

Hugh P. Skottowe phd

Rona yaeger MD

Andrea cercek MD

Anne lincoln MS

Christina tran BS

Neil H. Segal MD, phd

Diane L. Reidy MD

Anna varghese MD

Andrew S. Epstein MD

Yukio sonoda MD

Dennis chi MD

Jose guillem MD

Larissa temple MD

Philip paty MD

Jaclyn hechtman MD

Jinru shia MD

Martin weiser MD

Julio garcia aguilar MD, phd

Nancy kemeny MD

Michael F. Berger phd

Leonard saltz MD

Zsofia K. Stadler MD

Pages: 1134-1143

First published: 22 november 2016

The results of this large retrospective study of patients with ovarian metastases from colorectal cancer demonstrate that patients who undergo complete surgical resection of all macroscopic metastatic disease have a better prognosis than those who undergo incomplete surgical resection. In addition, the authors identify tumor mutations specifically associated with ovarian metastases and with poor survival, thus laying the foundation for future genetic risk stratification of candidates for oophorectomy.

Gynecologic oncology

Synuclein‐γ in uterine serous carcinoma impacts survival: an NRG oncology/gynecologic oncology group study

Abigail D. Winder MD

Kruti P. Maniar MD

Jian‐jun wei MD

Dachao liu MS

Denise M. Scholtens phd

John R. Lurain MD

Julian C. Schink MD

Barbara M. Buttin MD

Virginia L. Filiaci phd

Heather A. Lankes phd, MPH

Nilsa C. Ramirez MD

Kay park MD

Meenakshi singh MD

Richard W. Lieberman MD

Robert S. Mannel MD

Matthew A. Powell MD

Floor J. Backes MD

Cara A. Mathews MD

Michael L. Pearl MD

Angeles alvarez secord MD

David J. Peace MD

David G. Mutch MD

William T. Creasman MD

J. Julie kim phd

Pages: 1144-1155

First published: 07 december 2016

Synuclein‐γ, along with p53 and p16, is associated with worse overall and progression‐free survival in women with uterine serous carcinoma. The association of synuclein‐γ with markers of advanced disease merits further investigation of its role in uterine serous carcinoma biology or as a predictive biomarker, and its ability to predict chemoresistance remains to be studied.

Head and neck disease

Significant changes in sexual behavior after a diagnosis of human papillomavirus‐positive and human papillomavirus‐negative oral cancer

Miren taberna MD

Ronald C. Inglehart

Robert K. L. Pickard

Carole fakhry MD, MPH

Amit agrawal MD

Mira L. Katz phd

Maura L. Gillison MD, phd

Pages: 1156-1165

First published: 14 february 2017

Diagnosis and treatment of oral squamous cell carcinomas are associated with significant declines in the frequency of several sexual behaviors, regardless of tumor human papillomavirus status. Health care providers should be aware of these changes, be prepared to discuss them, and include their assessment in quality‐of‐life outcomes in clinical trials.

Hematologic malignancies

MYD88, CD79B, and CARD11 gene mutations in CD5‐positive diffuse large B‐cell lymphoma

Toshifumi takeuchi MD

Motoko yamaguchi MD, phd

Kyoko kobayashi MD, phd

Kana miyazaki MD, phd

Isao tawara MD, phd

Hiroshi imai MD, phd

Ryoichi ono MD, phd

Tetsuya nosaka MD, phd

Kyosuke tanaka MD, phd

Naoyuki katayama MD, phd

Pages: 1166-1173

First published: 04 december 2016

The frequency of myeloid differentiation primary response 88 (MYD88) and CD79B gene mutations in CD5‐positive diffuse large B‐cell lymphoma (DLBCL) is lower than that in primary DLBCL occurring within sanctuary sites. Caspase recruitment domain family member 11 (CARD11) gene mutations are uncommon in patients with CD5‐positive DLBCL.

A prospective cohort study of patients with peripheral T‐cell lymphoma in the united states

Kenneth R. Carson MD, phd

Steven M. Horwitz MD

Lauren C. Pinter‐brown MD

Steven T. Rosen MD

Barbara pro MD

Eric D. Hsi MD

Massimo federico MD

Christian gisselbrecht MD

Marc schwartz BS

Lisa A. Bellm MIM

Mark A. Acosta pharmd

Andrei R. Shustov MD

Ranjana H. Advani MD

Tatyana A. Feldman MD

Mary jo lechowicz MD

Sonali M. Smith MD

Frederick lansigan MD

Anil tulpule MD

Michael D. Craig MD

John P. Greer MD

Brad S. Kahl MD

Joseph W. Leach MD

Neil morganstein MD

Carla casulo MD

Steven I. Park MD

Francine M. Foss MD

Pages: 1174-1183

First published: 02 december 2016

There is no clear standard of care in the treatment of patients with peripheral T‐cell lymphoma in the united states. Although efforts to improve frontline treatments are necessary, anthracyclines remain an important component of initial therapy for curative intent.

Differential mutation frequencies in metastatic cutaneous squamous cell carcinomas versus primary tumors

Ayse selen yilmaz MS

Hatice gulcin ozer phd

Jessica L. Gillespie BA

Dawn C. Allain MS

Madison N. Bernhardt BS

Karina colossi furlan MD

Leticia T. F. Castro MD

Sara B. Peters MD

Priyadharsini nagarajan MD, phd

Stephen Y. Kang MD

O. Hans iwenofu MD

Thomas olencki DO

Theodoros N. Teknos MD

Amanda ewart toland phd

Pages: 1184-1193

First published: 01 december 2016

Exome and/or targeted deep sequencing analysis of 10 primary cutaneous squamous cell carcinoma (cscc) and 18 metastatic cscc samples demonstrated mutations in known skin cancer‐related genes such as TP53 and NOTCH1. Combining frequency data from primary and metastatic csccs from the current study with those in the literature demonstrated a higher mutation frequency in TP53 and KMT2D in metastatic tumors compared with nonmetastatic cscc samples.

Soft tissue and bone sarcoma

Clinical genomic profiling identifies TYK2 mutation and overexpression in patients with neurofibromatosis type 1‐associated malignant peripheral nerve sheath tumors

Angela C. Hirbe MD, phd

Madhurima kaushal MS

Mukesh kumar sharma phd

Sonika dahiya MD

Melike pekmezci MD

Arie perry MD

David H. Gutmann MD, phd

Pages: 1194-1201

First published: 22 november 2016

Neurofibromatosis type 1‐associated malignant peripheral nerve sheath tumors are deadly sarcomas with few treatment options. Using clinical‐grade genomic profiling, tyrosine kinase 2 (TYK2) was identified as a new gene that is mutated and overexpressed in malignant peripheral nerve sheath tumors.

Discipline

Epidemiology

Hepatitis C virus infection and the risk of cancer among elderly US adults: A registry‐based case‐control study

Parag mahale MBBS, phd

Harrys A. Torres MD

Jennifer R. Kramer phd

Lu‐yu hwang MD

Ruosha li phd

Eric L. Brown phd

Eric A. Engels MD, MPH

Pages: 1202-1211

First published: 24 january 2017

Chronic hepatitis C virus infection is a cause of hepatocellular carcinoma, but its associations with other cancers are uncertain. Nationally representative data from an elderly US population in the surveillance, epidemiology, and end results‐medicare–linked database indicates that hepatitis C virus is associated with increased risks of intrahepatic and extrahepatic cholangiocarcinoma and diffuse large B‐cell lymphoma.

Medical oncology

Surveillance versus adjuvant radiotherapy for patients with high‐risk stage I seminoma

Mette S. Mortensen MD

Mikkel bandak MD

Maria G. G. Kier MD

Jakob lauritsen MD

Mads agerbæk MD

Niels V. Holm MD, phd

Hans von der maase MD, dmsc

Gedske daugaard MD, dmsc

Pages: 1212-1218

First published: 28 november 2016

The treatment of patients with high‐risk, stage I seminoma has shifted from adjuvant radiotherapy to surveillance in many centers. Although the risk of disease recurrence is much higher after surveillance, the authors report no differences in overall survival or in the risk of receiving >1 treatment line when comparing the patients followed with surveillance with those who received adjuvant radiotherapy.

Outcomes research

The impact of health insurance on cancer care in disadvantaged communities

Individuals from disadvantaged communities are among the millions of uninsured americans gaining insurance under the affordable care act. This study examines whether health insurance and better access to care can mitigate the effects of the social determinants of health on cancer care for the leading 4 causes of cancer deaths in the united states.

Candyce H. Kroenke scd, MPH

Yvonne L. Michael phd

Elizabeth M. Poole scd

Marilyn L. Kwan phd

Sarah nechuta phd

Eric leas phd

Bette J. Caan drph

John pierce phd

Xiao‐ou shu MD

Ying zheng phd

Wendy Y. Chen MD

Pages: 1228-1237

First published: 12 december 2016

A large, prospective, pooled cohort study of 9267 women with breast cancer shows that women who are socially isolated have higher risks of recurrence, breast cancer–specific mortality, and overall mortality. In analyses of specific ties and outcomes, specific associations differ by age, race/ethnicity, and country of origin, and this suggests that critical supports differ with sociodemographic factors.

Pediatric oncology

Short‐term and long‐term effects of childhood cancer on income from employment and employment status: A national cohort study in sweden

Annika lindahl norberg phd

Scott M. Montgomery phd

Matteo bottai phd

Mats heyman MD, phd

Emma I. Hovén phd

Pages: 1238-1248

First published: 21 november 2016

Parents' income from employment and employment status are adversely affected by having a child with cancer, but the effects are not distributed equally. In particular, more support and financial assistance may be advocated for young parents, mothers with a lower educational level, and mothers who were born in another country.

Survivorship

Effect of the LIVESTRONG at the YMCA exercise program on physical activity, fitness, quality of life, and fatigue in cancer survivors

Melinda L. Irwin phd, MPH

Brenda cartmel phd

Maura harrigan MS

Fangyong li MS

Tara sanft MD

Laura shockro MPH

Keelin O'connor BA

Nancy campbell BA

Sara M. Tolaney MD

Erica L. Mayer MD

Rachel yung MD

Rachel A. Freedman MD

Ann H. Partridge MD

Jennifer A. Ligibel MD

Pages: 1249-1258

First published: 28 november 2016

The LIVESTRONG at the young men's christian association (YMCA) exercise program is safe and effective for improving physical activity, fitness, fatigue, and quality of life in cancer survivors. This program has the potential to impact thousands of survivors across the YMCA network and could lead to improvements in disease and psychosocial outcomes in the growing population of cancer survivors.

Communication

Immunotherapy of head and neck cancer: emerging clinical trials from a national cancer institute head and neck cancer steering committee planning meeting

Julie E. Bauman MD, MPH

Ezra cohen MD

Robert L. Ferris MD, phd

David J. Adelstein MD

David M. Brizel MD

John A. Ridge MD, phd

Brian O'sullivan MD

Barbara A. Burtness MD

Lisa H. Butterfield phd

William E. Carson MD

Mary L. Disis MD

Bernard A. Fox phd

Thomas F. Gajewski MD, phd

Maura L. Gillison MD, phd

James W. Hodge phd, MBA

Quynh‐thu le MD

David raben MD

Scott E. Strome MD

Jean lynn RN, MPH

Shakun malik MD

Pages: 1259-1271

First published: 01 december 2016

The national cancer institute sponsored a clinical trials planning meeting to address the issue of how to further investigate the use of immunotherapy in patients with head and neck squamous cell carcinoma. Although reviews usually are published immediately after the meeting is held, this report is unique because there are now tangible clinical trial designs that have been funded and put into practice and the studies currently are being activated to accrual.

Banco santander deja de remunerar la «cuenta 123»

La entidad, que con esta medida reducirá costes para afrontar el actual entorno de tipos de interés negativos, eliminará a cambio las comisiones de 72 euros al año ligadas al banco

moncho veloso SEGUIR madrid actualizado: 31/10/2019 22:58h

Banco santander ha dado un viraje en su oferta comercial en españa y suprimirá las ventajas económicas de la «cuenta 123», el producto estrella que lanzó en 2015 dentro de su estrategia para elevar el número de clientes vinculados, que suman ya 2,5 millones de personas. A partir del próximo mes de enero, la entidad presidida por ana botín dejará de remunerar el saldo en cuenta de los clientes con este productos y de bonificar los recibos que tengan domiciliados. A cambio, el banco quitará todas las comisiones ligadas a esta cuenta corriente.

La decisión del primer banco del país se enmarca en la necesidad de las entidades financieras de reducir costes en un escenario en el que los tipos de interés negativos del banco central europeo (BCE) lastra los ingresos de los bancos y ha suscitado incluso un debate en el sector sobre si las entidades van a cobrar o no a los depositantes por sus ahorros. Lo cierto es que el santander ya había ido reduciendo desde su lanzamiento en 2015 los beneficios económicos de la cuenta, justificándolo siempre por esa necesidad de reducir gastos.

En ese contexto, el santander dejará ahora de remunerar al 3% los saldos de hasta 1.000 euros de los titulares de la «cuenta 123», como hacía hasta ahora. Además, ya no les abonará un 3% de los recibos de luz, agua, gas e internet, entre otros, que tengan domiciliados en esa cuenta. Como compensación, eso sí, el banco dejará de cobrar a estos clientes los 3 euros al mes de cuota de mantemiento de la cuenta y otros 3 euros al mes de mantenimiento de las tarjetas asociadas a la cuenta que les cobraba hasta ahora y que suponían un coste anual para el cliente de 72 euros.

Temas

Escucha todos los capítulos del podcast de reportajes de ABC

Torres-dulce: «decapitar estatuas es como decapitar la historia»

Oferta ITV madrid - OCA ITV

Ver oferta

Código descuento vueling

Queremos conocerte para poder ofrecerte los contenidos según tus preferencias ¿podrías respondernos unas breves preguntas?

No te llevará más de un minuto.
¡gracias por adelantado!

Aceptar ahora no queremos conocerte 1 2

Por favor ¿nos puedes facilitar tu fecha de nacimiento y género?

Por favor, marca uno o varios temas que sean de tu interés.

Aceptar omitir este paso queremos conocerte

Tools

Follow journal

Journal of surgical oncology

Export citations

ISSUE INFORMATION

Issue information ‐ ed board

Issue information ‐ TOC

HOW I DO IT

How to maintain elective treatment of breast cancer during the COVID‐19 pandemic—A cancer center experience

Fernanda P. M. Leite

Carla curi

Solange M. Sanches

Maria P. Curado

Gisele A. Fernandes

Samira moraes

Marina sonagli

Raquel bussolotti

Victor P. De andrade

Ivan L. A. F. E silva

Fabiana B. A. Makdissi

Pages: 9-11

First published: 28 september 2020

REVIEW ARTICLES

Strategies for care of patients with gastrointestinal stromal tumor or soft tissue sarcoma during COVID‐19 pandemic: A guide for surgical oncologists

Dario callegaro MD

Chandrajit P raut MD, msc

Emily Z keung MD, AM

Teresa kim MD

Cecile le pechoux MD

Javier martin‐broto MD, phd

Alessandro gronchi MD

Carol swallow MD, phd

Rebecca gladdy MD, phd

Pages: 12-23

First published: 06 october 2020

RESEARCH ARTICLES

Impact of COVID‐19 lockdown measures on oncological surgical activity: analysis of the surgical pathology caseload of a tertiary referral hospital in northwestern italy

Elena vissio MD

Enrico costantino falco MD

Giammarco collemi BS

Fulvio borella MD

Mauro papotti MD

Antonio scarmozzino MD

Paola cassoni MD phd

Luca bertero MD phd

Pages: 24-31

First published: 20 october 2020

REVIEW ARTICLES

Impact of the COVID‐19 pandemic during spain's state of emergency on the diagnosis of colorectal cancer

Javier suárez MD

Elena mata MD

Ana guerra MD

Gloria jiménez MD

Marta montes MD

Fernando arias phd

Miguel A. Ciga phd

Eugenia ursúa MD

María ederra MD

Beñat arín

Matilde laiglesia

Asunción sanz

Ruth vera MD

Pages: 32-36

First published: 19 october 2020

EDITORIAL

Completion thyroidectomy—have we made appropriate decisions?

The role and therapeutic implications of PI3K signaling pathway in cancer

Premila D. Leiphrakpam MBBS, phd

Sanjib chowdhury phd

Jing wang phd

Jennifer D. Black phd

Chandrakanth are MD, MBA, FSSO, FRCS, FACS

Pages: 39-41

First published: 12 november 2020

RESEARCH ARTICLES

Correlation of PRL3 expression with colorectal cancer progression

Premila D. Leiphrakpam MBBS, phd

Audrey J. Lazenby MD

Lynette M. Smith phd

Michael G. Brattain phd

Jennifer D. Black phd

Jing wang phd

Chandrakanth are MD, MBA, FSSO, FRCS, FACS

Pages: 42-51

First published: 12 november 2020

REVIEW ARTICLES

Patient generated health data and electronic health record integration in oncologic surgery: A call for artificial intelligence and machine learning

Laleh G. Melstrom MD MSCI

Andrei S. Rodin phd

Lorenzo A. Rossi phd

Paul fu jr MD MPH

Yuman fong MD

Virginia sun RN phd

Pages: 52-60

First published: 24 september 2020

RESEARCH ARTICLES

Metaplastic breast cancer: prognostic and therapeutic considerations

Giovanni corso MD, phd

Samuele frassoni

Antonia girardi MD

Elisa de camilli MD

Emilia montagna MD

Mattia intra MD

Luca bottiglieri MD

Alessandra margherita de scalzi MD

Denise mattar fanianos MD

Francesca magnoni MD, phd

Alessandra invento MD

Antonio toesca MD

Fabio conforti MD

Vincenzo bagnardi

Giuseppe viale MD

Marco angelo colleoni MD

Paolo veronesi MD

Pages: 61-70

First published: 12 october 2020

Leveraging the increased rates of pathologic complete response after neoadjuvant treatment in breast cancer to de‐escalate surgical treatments

Antonio esgueva MD, phd

Christian siso MD

Martin espinosa‐bravo MD, phd

Carolina sobrido MD, phd

Ignacio miranda MD

Juan P. Salazar MD, phd

Isabel T. Rubio MD, phd

Pages: 71-79

First published: 01 october 2020

First‐year complications after immediate breast reconstruction with a biological and a synthetic mesh in the same patient: A randomized controlled study

Emma hansson MD, MA, phd

Ann‐chatrin edvinsson RN

Anna elander MD, phd

Lars kölby MD, phd

Håkan hallberg MD, phd

Pages: 80-88

First published: 13 october 2020

Predictive value of tumor‐infiltrating lymphocytes for response to neoadjuvant chemotherapy and breast cancer prognosis

Xiaomin li MD

Qiuwen tan MD, phd

Hongjiang li MD

Xiaoqin yang MD, phd

Pages: 89-95

First published: 12 october 2020

Combined pedicled superficial circumflex iliac artery perforator (SCIP) flap with lymphatic tissue preservation and lymphovenous anastomosis (LVA) for defect reconstruction and lymphedema–lymphocele prevention in thigh sarcoma surgery: preliminary results

Mario F. Scaglioni MD

Matteo meroni MD

Elmar fritsche MD

Bruno fuchs MD, phd

Pages: 96-103

First published: 22 september 2020

Sentinel lymph node biopsy is associated with increased cost in higher risk thin melanoma

Taylor J. Aiken MD

Christopher C. Stahl MD

Patrick B. Schwartz MD

James barrett MD

Alexandra W. Acher MD

Deborah lemaster MS

Glen leverson phd

Sharon weber MD

Heather neuman MD, MS

Daniel E. Abbott MD

Pages: 104-109

First published: 16 september 2020

Patient‐reported functional outcomes in a cohort of hand and foot sarcoma survivors treated with limb sparing surgery and radiation therapy

Safia K. Ahmed MD

Suneetha kaggal BA

William S. Harmsen MS

Jessica W. Sawyer MD

Matthew T. Houdek MD

Peter S. Rose MD

Ivy A. Petersen MD

Pages: 110-116

First published: 30 october 2020

Characterising the immune microenvironment in liposarcoma, its impact on prognosis and the impact of radiotherapy

Hayden snow MBBS, FRACS

Catherine mitchell MBBS, FRCPA

Shona hendry MBBS, FRCPA

Madeleine mckinley MBBS, FRCPA

David byrne bbiomedsc(labmed)

Sam ngan MBBS, FRANZCR

Sarat chander MD, FRANZCR

Julie chu FRANZCR

Jayesh desai MBBS, FRACP

Susie bae MBBS, FRACP

Michael henderson MBBS, FRACS

Peter choong MD, FRACS

David gyorki MBBS, FRACS

Pages: 117-126

First published: 20 october 2020

Treatment outcome of superficial leiomyosarcoma

Elizabeth P. Wellings MD

Meagan E. Tibbo MD

Peter S. Rose MD

Andrew L. Folpe MD

Matthew T. Houdek MD

Pages: 127-132

First published: 15 october 2020

Comparison of reconstructive techniques following oncologic intraarticular resection of proximal humerus

Matthew T. Houdek MD

Brandon R. Bukowski MD

Alexander G. Athey MD

Bassem T. Elhassan MD

Jonathan D. Barlow MD

Mark E. Morrey MD

Peter S. Rose MD

Eric R. Wagner MD

Joaquin sanchez‐sotelo MD, phd

Pages: 133-140

First published: 23 october 2020

Nodal characteristics associated with adverse prognosis in oral cavity cancer are linked to host immune status

Cristina valero MD, phd

Daniella K. Zanoni MD

Anjali pillai msc

Bin xu MD, phd

Nora katabi MD

Ronald A. Ghossein MD

Ian ganly MD, phd

Luc G. T. Morris MD, msc

Jatin P. Shah MD

Richard J. Wong MD

Snehal G. Patel MD

Pages: 141-148

First published: 24 september 2020

Oncologic and functional outcomes following laryngectomy for locally advanced thyroid cancer

Stephanie flukes MBBS

Marc A. Cohen MD, MPH

Louise M. Cunningham MS, CCC‐SLP

Richard J. Wong MD, phd

Jennifer R. Cracchiolo MD

Pages: 149-155

First published: 15 october 2020

Shuang liu MD

Zheng lin phd

Jianbo lin MD

Huilin chen BD

Qianwen xie MD

Wenqing rao MD

Yuanmei chen MD

Kaili yu MD

Zhijian hu phd

Pages: 156-163

First published: 30 october 2020

REVIEW ARTICLES

Outcomes of neoadjuvant therapy for cholangiocarcinoma: A review of existing evidence assessing treatment response and R0 resection rate

Viet H. Le MD, MS

Victoria V. O'connor MD

Daneng li MD

Laleh G. Melstrom MD, MS

Yuman fong MD

Andrew L. Difronzo MD

Pages: 164-171

First published: 24 september 2020

RESEARCH ARTICLES

Yttrium‐90 radiation segmentectomy for hepatic metastases: A multi‐institutional study of safety and efficacy

Siddharth A. Padia MD

Guy E. Johnson MD

Vatche G. Agopian MD

Joseph dinorcia III MD

Ravi N. Srinivasa MD

James sayre

David S. Shin MD

Pages: 172-178

First published: 17 september 2020

Impact of ablation algorithm versus tumor‐dependent parameters on local control after microwave ablation of malignant liver tumors

Ozgun erten MD

Pengpeng li MD

Mehmet gokceimam MD

Serkan akbulut MD

Eren berber MD, MBA

Pages: 179-186

First published: 25 september 2020

A novel preoperative risk score to optimize patient selection for performing concomitant liver resection with cytoreductive surgery/HIPEC

Rachel M. Lee MD, MSPH

Adriana C. Gamboa MD

Michael K. Turgeon MD

Mohammad Y. Zaidi

Charles kimbrough MD

Jennifer leiting MD

Travis grotz MD

Andrew J. Lee

Keith fournier MD

Benjamin powers MD, MS

Sean dineen MD

Joel M. Baumgartner MD

Jula veerapong MD

Harveshp mogal MD

Callisia clarke MD

Gregory wilson MD

Sameer patel MD

Ryan hendrix MD

Laura lambert MD

Courtney pokrzywa MD

Daniel E. Abbott MD

Christopher J. Larocca MD

Mustafa raoof MD

Jonathan greer MD

Fabian M. Johnston MD, MHS

Charles A. Staley MD

Jordan M. Cloyd MD

Shishir K. Maithel MD

Maria C. Russell MD

Pages: 187-195

First published: 01 october 2020

Predictive significance of tumor budding in postoperative liver metastasis of pancreatic neuroendocrine tumors

Yuanxiang lu MD

Wensen li MD

Senmao mu MD

Lianyuan tao MD

Guoyi yan MD

Erwei xiao MD

Liancai wang MD

Deyu li MD

Pages: 196-203

First published: 29 september 2020

Metastatic renal cell carcinoma to the pancreas: clinical features and treatment outcome

Teak jun shin MD

Cheryn song MD, phd, MPH

Chang wook jeong MD, phd

Cheol kwak MD, phd

Seongil seo MD, phd

Minyong kang MD, phd

Jinsoo chung MD, phd

Sung‐hoo hong MD, phd

Eu chang hwang MD, phd

Jae young park MD, phd

Hakmin lee MD, phd

Pages: 204-213

First published: 12 october 2020

Actual 10‐year survivors and 10‐year recurrence free survivors after primary liver resection for hepatocellular carcinoma in the 21st century: A single institution contemporary experience

Yun le linn MBBS

Madeline Y. Chee MBBS

Ye‐xin koh MBBS, frcsed

Jin‐yao teo MBBS, frcsed

Peng‐chung cheow MBBS, frcsed

Pierce K. H. Chow MBBS, phd, frcsed

Chung‐yip chan MBBS, mmed, MD, frcsed

Alexander Y. F. Chung MBBS, frcsed

London L. P. J. Ooi MBBS, MD, FCSHK (hon), frcsed, FRCSG

Brian K. P. Goh MBBS, mmed, frcsed

Pages: 214-221

First published: 23 october 2020

Microscopic portal vein invasion is a powerful predictor of prognosis in patients with hepatocellular carcinoma who have undergone liver resection

Fang‐ying kuo MD

Yueh‐wei liu MD

Chih‐che lin MD, phd

Chee‐chien yong MD

Chih‐chi wang MD

Chao‐long chen MD

Yu‐fan cheng MD

Jing‐houng wang MD

Yi‐hao yen MD

Pages: 222-235

First published: 20 october 2020

Sex‐based differences in time to surgical care among pancreatic cancer patients: A national study of medicare beneficiaries

Rosevine A. Azap BS

James M. Hyer MS

Adrian diaz MD, MPH

Diamantis I. Tsilimigras MD

Rayyan S. Mirdad MBBS

Timothy M. Pawlik MD, MPH, phd

Pages: 236-244

First published: 20 october 2020

Neoadjuvant therapy versus upfront surgery for early‐stage left‐sided pancreatic adenocarcinoma: A propensity‐matched analysis from a national cohort of distal pancreatectomies

Ibrahim nassour MD, MSCS

Mohamed A. Adam MD

Stacy kowalsky MD

Samer al masri MD

Nathan bahary MD, phd

Aatur D. Singhi MD, phd

Kenneth lee MD

Amer zureikat MD

Alessandro paniccia MD

Pages: 245-251

First published: 25 october 2020

Safety and feasibility of initiating a hepatic artery infusion pump chemotherapy program for unresectable colorectal liver metastases: A multicenter, retrospective cohort study

Hala muaddi MD, msc

Michael D'angelica MD

Jason T. Wiseman MD, MSPH

Mary dillhoff MD

Nicholas latchana MD

Rachel roke bsc

Yoo‐joung ko MD, MMSC

Darren carpizo MD, phd

Kristen spencer DO

Ryan C. Fields MD

Gregory williams MA

Federico aucejo MD

Lou‐anne acevedo‐moreno MD

Kevin G. Billingsley MD

Brett S. Walker MD

Skye C. Mayo MD, MPH

Paul J. Karanicolas MD, phd

Pages: 252-260

First published: 23 october 2020

The intersection of tumor location and combined bowel preparation: utilization differs but anastomotic leak risk reduction does not

Nicholas P. Mckenna MD

Katherine A. Bews BA

Dorin T. Colibaseanu MD

Kellie L. Mathis MD

Heidi nelson MD

Elizabeth B. Habermann phd

Pages: 261-270

First published: 01 october 2020

Short‐term outcomes of pelvic floor peritoneum closure in endoscopic low anterior resection of rectal cancer: A propensity score matching analysis

Li chuan MD, phd

Gao linfeng MA

Liu hongchang MA

Wang xiaosong MD

Luo huaxing MD, phd

Zhang chao MD, phd

Peiwu yu MD, phd

Tang bo MD, phd

Pages: 271-277

First published: 12 october 2020

Impact of KRAS status on tumor response and survival after neoadjuvant treatment of locally advanced rectal cancer

Peige zhou MD

Paolo goffredo MD

Timothy ginader MS

Dakota thompson MD

Jennifer hrabe MD

Irena gribovskaja‐rupp MD

Muneera kapadia MD

Imran hassan MD

Pages: 278-285

First published: 06 october 2020

Even a partial pathological response is associated with lower relapse rates in patients with operable rectal cancer undergoing neoadjuvant chemotherapy

Michihiro koizumi MD, phd

Takeshi yamada MD, phd

Seiichi shinji MD, phd

Akihisa matsuda MD, phd

Yasuyuki yokoyama MD, phd

Goro takahashi MD, phd

Takuma iwai MD, phd

Kohki takeda MD, phd

Keisuke hara MD, phd

Hiroshi yoshida MD, phd

Pages: 286-292

First published: 06 october 2020

Ten‐year survival after pathologic complete response in rectal adenocarcinoma

Naomi M. Sell MD, MHS

Yasmeen Z. Qwaider MD

Robert N. Goldstone MD

Christy E. Cauley MD, MPH

James C. Cusack MD

Rocco ricciardi MD, MPH

Liliana G. Bordeianou MD, MPH

David L. Berger MD

Hiroko kunitake MD, MPH

Pages: 293-298

First published: 06 october 2020

Sphincter‐saving surgery for ultra‐low rectal carcinoma initially indicated for abdominoperineal resection: is it safe on a long‐term follow‐up?

Philippe rouanet MD, phd

Michel rivoire MD, phd

Sophie gourgou msc

Bernard lelong MD

Eric rullier MD, phd

Merhdad jafari MD

Laurent mineur MD

Marc pocard MD, phd

Jean luc faucheron MD, phd

François dravet MD

Denis pezet MD

Jean michel fabre MD, phd

Laurent bresler MD

Jacques balosso MD, phd

Christophe taoum MD

Claire lemanski MD

Pages: 299-310

First published: 24 october 2020

Inferior epigastric artery lymph nodes: A pathway for systemic dissemination from peritoneal carcinomatosis?

Antoine el asmar MD

Isabelle veys MD

Denis larsimont phd

Vincent donckier phd

Gabriel liberale phd

Pages: 311-314

First published: 30 october 2020

Tailoring the radiotherapy approach in patients with anal squamous cell carcinoma based on inguinal sentinel lymph node biopsy

Paola de nardi MD, FASCRS

Massimiliano mistrangelo MD, phd

Giovanni burtulo MD

Paolo passoni MD

Najla slim MD

Monica ronzoni MD

Carla canevari MD

Danilo parolini MD

Luca massimino phd, msc

Pierfrancesco franco MD, phd

Paola cassoni MD, phd

Adriana lesca MD

Valentina testa MD

Riccardo rosati MD

Pages: 315-321

First published: 22 september 2020

Active surveillance or early resection for ground‐glass nodules that need preoperative localization

Ping‐chung tsai

Po‐kuei hsu

Yi‐chen yeh

Chun‐ku chen

Ying‐yueh chang

Chien‐sheng huang

Han‐shui hsu

Pages: 322-331

First published: 28 september 2020

Clinicopathological and prognostic features of operable non‐small cell lung cancer patients with diabetes mellitus

Kaoru kaseda MD

Tomoyuki hishida MD

Kyohei masai MD

Keisuke asakura MD

Yuichiro hayashi MD

Hisao asamura MD

Pages: 332-341

First published: 01 october 2020

Multidisciplinary approach for repeat musculoskeletal lesion biopsy after nondiagnostic initial sampling: A 10‐year single‐center experience

Salim abboud MD

Vijaya kosaraju MD

Aashish bhatt MD

Rachel egler MD

Robin elliott MD

Navid faraji MD

Ankit mangla MD

David mansur MD

Luke rothermel MD

Shahrazad saab MD

Peter young MD

Patrick getty MD

Christos kosmas MD

Pages: 342-351

First published: 13 october 2020

Opioid prescribing exceeds consumption following common surgical oncology procedures

Nicholas W. Eyrich MS

Kenneth R. Sloss BS

Ryan A. Howard MD

Michael P. Klueh MD

Michael J. Englesbe MD

Jennifer F. Waljee MD, MPH, MS

Chad M. Brummett MD

Michael S. Sabel MD

Lesly A. Dossett MD, MPH

Jay S. Lee MD

Pages: 352-356

First published: 30 october 2020

LETTER TO THE EDITOR

Apples and oranges: comparison of two surgical procedures with different indications for the management of oral squamous cell carcinoma

Deep chakrabarti MD

Shiv rajan MS, mch

Mranalini verma MD

Naseem akhtar MS, mch

Vijay kumar MS, mch

Pages: 357-358

First published: 01 december 2020

Telemedicine and cancer research during the COVID‐19 pandemic

RESPONSE TO LETTER TO THE EDITOR

First, do no harm

Tools

Additional links

About wiley online library

Help & support

Opportunities

Connect with wiley

Log in to wiley online library

Change password

Password changed successfully

Your password has been changed

Create a new account

Forgot your password?

Enter your email address below.

Please check your email for instructions on resetting your password. If you do not receive an email within 10 minutes, your email address may not be registered, and you may need to create a new wiley online library account.